Is There Any Relationship Between Helicobacter pylori and Obesity, Metabolic Syndrome, and Non-alcoholic Fatty Liver Disease?
| Autor: | Rebeca Hernandez Lemus, Alejandro Hernandez Monroy |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty biology business.industry 030106 microbiology 030231 tropical medicine Fatty liver Adipokine Disease Helicobacter pylori medicine.disease biology.organism_classification Obesity Gastroenterology 03 medical and health sciences 0302 clinical medicine Infectious Diseases Insulin resistance Internal medicine Nonalcoholic fatty liver disease medicine Immunology and Allergy Metabolic syndrome business |
| Zdroj: | Current Tropical Medicine Reports. 8:212-217 |
| ISSN: | 2196-3045 |
| DOI: | 10.1007/s40475-021-00240-7 |
| Popis: | To determine if there is a relationship between Helicobacter pylori (H. pylori) and metabolic disorders such as obesity, metabolic syndrome, and nonalcoholic fatty liver disease. H. pylori is a bacterium that affects almost 50% of the world population. New information shows that it may have a relationship with metabolic disorders. This relationship might be induced by regulation of adipokines and hormones, chronic inflammation, and insulin resistance. Contrasting, there has been reported weight gain after the eradication treatment. There is a strong relationship between H. pylori and nonalcoholic fatty liver disease (NAFLD), a less obvious relationship with obesity, and probably no relationship with metabolic syndrome. H. pylori–positive patients should be screened for obesity at the time of diagnosis. Eradication treatment must be done to avoid medical complications, and weight gain should be monitored. Early treatment of H. pylori infection may reduce the risk of NAFLD. Future studies should investigate a causal relationship between H. pylori and metabolic disorders. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink